Discovery of novel Quinazoline-based KRAS G12C inhibitors as potential anticancer agents (vol 71, 116962, 2022)

被引：0
|
作者：
Li, Ling [1 ,2 ]
Zhao, Huiting [2 ]
Peng, Xiaopeng [3 ]
Liu, Jin [2 ]
Mai, Ruiyao [2 ]
Chen, Jingxuan
Lin, Lin [4 ]
Chen, Ting [4 ]
Yan, Jun [5 ,6 ]
Shi, Jiaolong [5 ,6 ]
Chen, Jianjun [2 ,5 ,6 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 8, Shenzhen 518033, Peoples R China
[2] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China
[3] Gannan Med Univ, Coll Pharm, Ganzhou 314000, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Stomatol, Guangzhou 510515, Peoples R China
[5] Southern Med Univ, Dept Gen Surg, Guangzhou 510515, Guangdong, Peoples R China
[6] Southern Med Univ, Nanfang Hosp, Sch Clin Med 1, Guangdong Prov Key Lab Precis Med Gastrointestinal, Guangzhou 510515, Guangdong, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2024年 / 111卷
关键词：
D O I：
10.1016/j.bmc.2024.117840
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 43 条
  • [41] Discovery of novel 7,8-dihydropteridine-6(5H)-one-based DNA-PK inhibitors as potential anticancer agents via scaffold hopping strategy
    Ding, Zongbao
    Pan, Wei
    Xiao, Yao
    Cheng, Binbin
    Huang, Gang
    Chen, Jianjun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 237
  • [42] Discovery and biological evaluation of 1-{2,7-diazaspiro[3.5]nonan-2-yl} prop-2-en-1-one derivatives as covalent inhibitors of KRAS G12C with favorable metabolic stability and anti-tumor activity
    Imaizumi, Tomoyoshi
    Akaiwa, Michinori
    Abe, Tomoaki
    Nigawara, Takahiro
    Koike, Takanori
    Satake, Yoshiki
    Watanabe, Kazushi
    Kaneko, Osamu
    Amano, Yasushi
    Mori, Kenichi
    Yamanaka, Yosuke
    Nagashima, Takeyuki
    Shimazaki, Masashi
    Kuramoto, Kazuyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 71
  • [43] Discovery of ASP6918, a KRAS G12C inhibitor: Synthesis and structure-activity relationships of 1-{2,7-diazaspiro[3.5]non-2-yl} prop-2-en-1-one derivatives as covalent inhibitors with good potency and oral activity for the treatment of solid tumors
    Imaizumi, Tomoyoshi
    Shimada, Itsuro
    Satake, Yoshiki
    Yamaki, Susumu
    Koike, Takanori
    Nigawara, Takahiro
    Kaneko, Osamu
    Amano, Yasushi
    Mori, Kenichi
    Yamanaka, Yosuke
    Nakayama, Ayako
    Nishizono, Yoshihiro
    Shimazaki, Masashi
    Nagashima, Takeyuki
    Kuramoto, Kazuyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 98
12345